Theta Burst TMS for Treatment of Methamphetamine Use Disorder

Carilion Clinic

Status: Enrolling

Conditions: Methamphetamine Abuse

Treatments: Device: Transcranial Magnetic Stimulation; Device: Sham Transcranial Magnetic Stimulation

Study type: Interventional

Funder types: Other

Identifiers

NCT06372288

22-1754

Details and patient eligibility

About

This study is using Transcranial Magnetic Stimulation (TMS) to determine if interventional psychiatry treatment can help with the treatment of Methamphetamine Use Disorder. Individuals with Methamphetamine Use Disorder will receive 5 consecutive TMS treatment sessions based off of randomization. Participants will be randomized to one of two groups. TMS treatment arm or sham-TMS arm.

Full description

Patients who meet criteria for the study and who agree to participate in the research study will be randomized to an arm of the study by chance (like tossing a coin). The chance of receiving TMS or sham-TMS is equal. They will be enrolled in either the TMS or sham-TMS group (both groups involve 5 TMS or sham-TMS sessions). The study doctor and the participant will not know whether they are in the TMS or sham-TMS group. The purpose of this study is to determine if TMS is a potential treatment for methamphetamine use disorder. TMS is a non-invasive technique that uses magnetic pulses to temporarily stimulate specific brain areas in awake people (without the need for surgery, anesthetic, or other invasive procedures). This study will test whether a specific type of TMS (intermittent theta burst) over the forehead can produce a reduction in things that may prompt you to want to use methamphetamines.

Enrollment: 40 estimated patients

Sex: All

Ages: 18 to 55 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Individuals actively struggling with Methamphetamine Use Disorder
• Must be currently enrolled in Carilion Clinic Office Based Addiction Treatment (OBAT) program

Exclusion criteria

• Individuals currently struggling with alcohol use and/or benzodiazepine use

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

40 participants in 2 patient groups

Transcranial Magnetic Stimulation (TMS)

Experimental group

Description:

This arm receives the TMS treatments.

Treatment:

Device: Transcranial Magnetic Stimulation

Sham-TMS

Sham Comparator group

Description:

This arm receives sham TMS treatments.

Treatment:

Device: Sham Transcranial Magnetic Stimulation